Content area
Full text
LATEST COMPANY NEWS
News and Commentary
Personalised medicine trial for childhood cancers - 19/9/2017
Personalised medicine for childhood cancers in Australia is now one step closer, following launch of the Zero Childhood Cancer program's national clinical trial.
For the complete story see:
http://www.labonline.com.au/content/life-scientist/news/personalised-medicine-trial-for-childhood-cancers-1465087072
Hemp Gazette - Australian Rural Doctors Preparing For Medicinal Cannabis - 18/9/2017
Clearing up confusion regarding medical cannabis will be a key topic at the upcoming Rural Medicine Australia conference in Melbourne.
For the complete story see:
https://www.hempgazette.com/news/rural-doctors-medical-cannabis-hg0417/
Life Scientist - Diabetes drug found to have anti-ageing properties - 18/9/2017
Australian researchers have discovered that metformin, a common anti-diabetic drug, could have anti-ageing properties which could lead to longer, healthier lifespans.
For the complete story see:
http://www.labonline.com.au/content/life-scientist/news/diabetes-drug-found-to-have-anti-ageing-properties-170179902
PR Newswire - CSL Behring Announces FDA Approval of Privigen® [Immune Globulin Intravenous (Human), 10% Liquid] for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Adults - 14/9/2017
CIDP is a rare autoimmune disorder that affects the peripheral nerves and may cause permanent nerve damage.
For the complete story see:
http://www.prnewswire.com/news-releases/csl-behring-announces-fda-approval-of-privigen-immune-globulin-intravenous-human-10-liquid-for-the-treatment-of-chronic-inflammatory-demyelinating-polyneuropathy-cidp-in-adults-300520181.html
Baystreet.ca - United Cannabis Partners with Releaf Global to Enter Australian Market - 14/9/2017
Company grants new venture exclusive License to commercialize its patented Prana line throughout Australia.
For the complete story see:
https://www.baystreet.ca/viewarticle.aspx?id=475449
Proactive Investors Australia - BioTech Capital signs strategic agreement with Swedish medtech player - 13/9/2017
The company has won the rights to distribute two dental products.
For the complete story see:
http://www.proactiveinvestors.com.au/companies/news/183876/biotech-capital-signs-strategic-agreement-with-swedish-medtech-player-183876.html
Pharmacy News - Pharma spend on doctors falls 25% - 13/9/2017
Pharma spending on doctors doing consultancy work or speaking at educational events has dropped 25% since the industry was required to publicly name individual doctors receiving payments.
For the complete story see:
https://www.pharmacynews.com.au/pharma-spend-doctors-falls-25
CTV News - Canopy Growth signs deal to supply Australian company with medical cannabis - 13/9/2017
Canopy has signed an agreement with AusCann to be its exclusive supplier of medical cannabis for the Australian market.
For the complete story see:
http://www.ctvnews.ca/business/canopy-growth-signs-deal-to-supply-australian-company-with-medical-cannabis-1.3587651
https://www.facebook.com/acquisdata/
https://twitter.com/acquisdata
Media Releases
Medlab Clinical Ltd (ASX: MDC) - Medlab's Anti-Depression Product Granted 20 Year AU Patent - 18/9/2017
Medical life science company, Medlab Clinical Limited (ASX: MDC), has been granted a 20 year patent covering the Australian market for its probiotic product, NRGBiotic(TM).
Applications for patents in the United States,...